An Independent FDA: An Idea Whose Time Is Still Coming
This article was originally published in The Pink Sheet Daily
Despite strong support from six former agency commissioners, the notion of an FDA that is independent from HHS is likely to remain theoretical, at least for the near term.
You may also be interested in...
Former agency heads and outside experts suggest structural reforms in interviews with GAO. Report notes FDA had 10 political appointees in 2020 versus 5 in 2016 and 3 in 2022. House Select Subcommittee on the Coronavirus Crisis describes Trump Administration actions against FDA in its final report.
Robert Califf says there is a reason there is such a high turnover in the top post. He notes that the continuity and dedication of center directors is one of the reasons he returned.
Former commissioners continue push to move FDA out of HHS, but the alternative could create a different kind of political influence rather than eliminate it.